FDA Enforcement
Class II
Ongoing
Sequencing Agent SEQ0067, component of FoundationOne CDx (F1CDx)
Recall: Z-1927-2026
·
Reported April 29, 2026
Enforcement
- Recall Number
- Z-1927-2026
- Event ID
- 98625
- Classification
- Class II
- Status
- Ongoing
- Product Type
- Devices
- Firm
- Foundation Medicine, Inc.
- Voluntary / Mandated
- Voluntary: Firm initiated
- Initial Notification
- Report Date
- April 29, 2026
- Initiation Date
- March 20, 2026
- Classification Date
- April 22, 2026
- Address
- 150 2nd St, N/A, Cambridge, MA, 02141-2115, United States
Description
Sequencing Agent SEQ0067, component of FoundationOne CDx (F1CDx)
Reason
Possible increase in phasing, potentially resulting in false-positive BARD1 splice site indel artifact variants
Code Info
Model Number: SEQ0067. Lot Numbers: 24346, 24386, 24488.
Distribution
US Nationwide distribution in the states of Massachusetts and North Carolina.
Quantity
163 units